Clinical and Demographic Factors Influence Clinical Trial Enrollment

Clinical trial screening is a key siphon point in the clinical research pipeline, with biases in this step potentially informing treatment indications, medication outcomes, and overall generalizability of data to a population at large.1 Addressing clinical trial enrollment is a crucial step towards equity in medicine.2,3 Enrollment biases have been identified in stroke clinical trials previously, including enrolling larger strokes with higher NIHSS scores in Endovascular trials, underrepresentation of women, and missing NIHSS documentation in stroke registries.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research